Affiliation:
1. Health Services Research and Development Field Program and Ambulatory Care Service, Durham Veterans Administration Medical Center; and the Departments of Medicine and Community and Family Medicine, Duke University Medical Center Durham, North Carolina
Abstract
The goal of this study was to compare the relative efficacy and cost of self-monitoring of blood glucose (SMBG) with routine urine testing in the management of patients with type II (non-insulin-dependent) diabetes mellitus not treated with insulin. Fifty-four patients with type II diabetes mellitus, not treated with insulin, who had inadequate glucose control on diet aloneor diet and oral hypoglycemic agents were studied. Patients performed SMBG or urine glucose testing as part of a standardized treatment program that also included diet and exercise counseling. During the 6-mo study, both the urine-testing and SMBG groups showed similar improvement in glycemic control; within each group, there were significant improvements in fasting plasma glucose (reduction of 1.4 ± 3.2 mM, P < 0.03) and glycosylated hemoglobin (reduction of 2.0 ± 3.4%, P < 0.01) levels. Seventeen (31%) of54 patients actually normalized their glycosylated hemoglobin values, 9 in the urine-testing group and 8 in the SMBG group. Comparisons between the urine-testing and SMBG groups showed no significant differences in mean fasting plasma glucose (P > 0.86), glycosylated hemoglobin (P > 0.95), or weight (P < 0.19). In patients with type II diabetes mellitus not treated with insulin, SMBG is no more effective, but is 8–12 times more expensive, thanurine testing in facilitating improved glycemic control. Our results do not support widespread use of SMBG in diabetic patients not treated with insulin.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献